These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7535387)
1. Endothelin-1 stimulates the in vitro release of neurohypophyseal hormones, but not corticotropin-releasing hormone, via ETA receptors. Yasin S; Costa A; Navarra P; Pozzoli G; Kostoglou-Athanassiou I; Forsling M; Grossman A Neuroendocrinology; 1994 Dec; 60(6):553-8. PubMed ID: 7535387 [TBL] [Abstract][Full Text] [Related]
2. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide. Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902 [TBL] [Abstract][Full Text] [Related]
3. Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitro. Calogero AE; Raiti F; Nicolosi G; Burrello N; D'Agata R; Mantero F J Endocrinol; 1994 Mar; 140(3):419-24. PubMed ID: 8182369 [TBL] [Abstract][Full Text] [Related]
4. Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide. Kostoglou-Athanassiou I; Costa A; Navarra P; Nappi G; Forsling ML; Grossman AB J Neuroimmunol; 1998 Jun; 86(1):104-9. PubMed ID: 9655478 [TBL] [Abstract][Full Text] [Related]
5. Characterization of endothelin-1-induced vascular effects in the rat heart by using endothelin receptor antagonists. Wang QD; Li XS; Pernow J Eur J Pharmacol; 1994 Dec; 271(1):25-30. PubMed ID: 7698210 [TBL] [Abstract][Full Text] [Related]
6. Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Yasin SA; Costa A; Besser GM; Hucks D; Grossman A; Forsling ML Endocrinology; 1993 Mar; 132(3):1329-36. PubMed ID: 8440190 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Costa A; Trainer P; Besser M; Grossman A Brain Res; 1993 Mar; 605(2):187-92. PubMed ID: 8481768 [TBL] [Abstract][Full Text] [Related]
8. Modulation of ET(B) receptor-induced arginine-vasopressin secretion by N-methyl-D-aspartate (NMDA) and gamma-aminobutyric acid (GABA)-dependent mechanisms in hypothalamo-neurohypophysial explants. Rossi NF; Chen H Clin Sci (Lond); 2002 Aug; 103 Suppl 48():162S-166S. PubMed ID: 12193077 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide modulation of ET(B) receptor-induced vasopressin release by rat and mouse hypothalamo-neurohypophyseal explants. Rossi NF; Beierwaltes WH Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1208-15. PubMed ID: 16357097 [TBL] [Abstract][Full Text] [Related]
10. Regulation of vasopressin secretion by ETA and ETB receptors in compartmentalized rat hypothalamo-neurohypophysial explants. Rossi NF Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E535-41. PubMed ID: 14665445 [TBL] [Abstract][Full Text] [Related]
11. [Demonstration of a vasopressor role of endogenous endothelin after inhibition of nitric oxide synthesis in rats]. Richard V; Hogie M; Clozel M; Löffler BM; Thuillez C Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1213-6. PubMed ID: 8572876 [TBL] [Abstract][Full Text] [Related]
13. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR Neuroendocrinology; 2002 Nov; 76(5):316-24. PubMed ID: 12457042 [TBL] [Abstract][Full Text] [Related]
14. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. Ivy DD; Kinsella JP; Abman SH J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants. Costa A; Yasin SA; Hucks D; Forsling ML; Besser GM; Grossman A Endocrinology; 1992 Dec; 131(6):2595-602. PubMed ID: 1359961 [TBL] [Abstract][Full Text] [Related]
16. Involvement of nitric oxide in basal and interleukin-1 beta-induced CRH and ACTH release in vitro. Brunetti L; Preziosi P; Ragazzoni E; Vacca M Life Sci; 1993; 53(13):PL219-22. PubMed ID: 7690108 [TBL] [Abstract][Full Text] [Related]
17. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus. Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768 [TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor subtypes in resistance arteries from humans and rats. Deng LY; Li JS; Schiffrin EL Cardiovasc Res; 1995 Apr; 29(4):532-5. PubMed ID: 7796447 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide plays no role in ACTH release induced by interleukin-1 beta, corticotropin-releasing hormone, arginine vasopressin and phorbol myristate acetate in rat pituitary cell cultures. Hashimoto K; Nishioka T; Tojo C; Takao T Endocr J; 1995 Jun; 42(3):435-9. PubMed ID: 7545507 [TBL] [Abstract][Full Text] [Related]
20. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]